NASDAQ
Crinetics Pharmaceuticals, Inc. (CRNX) has a free cash flow growth of -34.45% as of Friday, May 29, 2026. This represents a 207.85% decrease compared to its 12-month average of -11.19%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.